Search

Your search keyword '"Protozoan Proteins genetics"' showing total 5,089 results

Search Constraints

Start Over You searched for: Descriptor "Protozoan Proteins genetics" Remove constraint Descriptor: "Protozoan Proteins genetics" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
5,089 results on '"Protozoan Proteins genetics"'

Search Results

1. Pilot-Scale Screening of Clinically Approved Drugs to Identify Uridine Insertion/Deletion RNA Editing Inhibitors in Trypanosoma brucei .

2. Identifying Rab2 Protein as a Key Interactor of Centrin1 Essential for Leishmania donovani Growth.

3. Deciphering Host-Parasite Interplay in Leishmania Infection through a One Health View of Proteomics Studies on Drug Resistance.

4. Protein disulfide isomerase PDI8 is indispensable for parasite growth and associated with secretory protein processing in Toxoplasma gondii .

5. CRISPR screens identify genes essential for in vivo virulence among proteins of hyperLOPIT-unassigned subcellular localization in Toxoplasma .

6. Constitutive upregulation of transcription factors underlies permissive bradyzoite differentiation in a natural isolate of Toxoplasma gondii .

7. Two Tetrahymena kinesin-9 family members exhibit slow plus-end-directed motility in vitro.

8. Molecular similarities between the genes for Trypanosoma cruzi microtubule-associated proteins, mammalian interferons, and TRIMs.

9. Characterization of the SUF FeS cluster synthesis machinery in the amitochondriate eukaryote Monocercomonoides exilis.

10. RESC14 and RESC8 cooperate to mediate RESC function and dynamics during trypanosome RNA editing.

11. mTORC1 pathway activity biases cell fate choice.

12. ARL3 GTPases facilitate ODA16 unloading from IFT in motile cilia.

13. Live-attenuated PruΔgra72 strain of Toxoplasma gondii induces strong protective immunity against acute and chronic toxoplasmosis in mice.

14. A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda.

15. Ex vivo susceptibilities to ganaplacide and diversity in potential resistance mediators in Ugandan Plasmodium falciparum isolates.

16. Therapeutic efficacy of pyronaridine-artesunate (Pyramax) in treating Plasmodium vivax malaria in the central highlands of Vietnam.

17. Extracellular vesicles released by Trypanosoma evansi: induction analysis and proteomics.

18. Intraflagellar transport speed is sensitive to genetic and mechanical perturbations to flagellar beating.

19. The C-terminus of CFAP410 forms a tetrameric helical bundle that is essential for its localization to the basal body.

20. Comparative GRA6 and GRA7 for their Utility as Genetic Markers in the Genotyping of Cerebral Toxoplasmosis in Cerebrospinal Fluid.

21. Cytokinetic abscission in Toxoplasma gondii is governed by protein phosphatase 2A and the daughter cell scaffold complex.

22. Evaluation of protective immunity induced by a DNA vaccine encoding SAG2 and SRS2 against Toxoplasma gondii infection in mice.

23. Spatio-temporal analysis of genetic diversity of merozoite surface protein-3 alpha in Myanmar Plasmodium vivax isolates.

24. CRISPR-based functional profiling of the Toxoplasma gondii genome during acute murine infection.

25. The emergence of artemisinin partial resistance in Africa: how do we respond?

26. Construction of Toxoplasma gondii SRS29C nucleic acid vaccine and comparative immunoprotective study of an SRS29C and SAG1 combination.

27. Lysine methyltransferase 2 plays a key role in the encystation process in the parasite Giardia lamblia.

28. Natural genetic diversity of the DBL domain of a novel member of the Plasmodium vivax erythrocyte binding-like proteins (EBP2) in the Amazon rainforest.

29. Role of PIP39 in oxidative stress response appears conserved in kinetoplastids.

30. Proteomic approaches for protein kinase substrate identification in Apicomplexa.

31. TKL family kinases in human apicomplexan pathogens.

32. Decoding Toxoplasma gondii virulence: the mechanisms of IRG protein inactivation.

33. Lack of selection of antimalarial drug resistance markers after intermittent preventive treatment of schoolchildren (IPTsc) against malaria in northeastern Tanzania.

34. The malaria parasite egress protease SUB1 is activated through precise, plasmepsin X-mediated cleavage of the SUB1 prodomain.

35. Trafficking of adhesion and aggregation-modulating proteins during the early stages of Dictyostelium development.

36. Transcriptome and proteome changes triggered by overexpression of the transcriptional regulator Maf1 in the human pathogen Leishmania major.

37. Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax.

38. Assessing the therapeutic efficacy of artemether-lumefantrine for uncomplicated malaria in Lagos, Nigeria: a comprehensive study on treatment response and resistance markers.

39. Novel Plasmodium falciparum histidine-rich protein 2/3 repeat type in Ethiopian malaria infection: does this affect performance of HRP2-based malaria RDT?

40. TgVax452, an epitope-based candidate vaccine targeting Toxoplasma gondii tachyzoite-specific SAG1-related sequence (SRS) proteins: immunoinformatics, structural simulations and experimental evidence-based approaches.

41. Identification and molecular characterization of a novel Babesia orientalis rhoptry neck protein 4 (BoRON4).

42. Single cell expression and chromatin accessibility of the Toxoplasma gondii lytic cycle identifies AP2XII-8 as an essential ribosome regulon driver.

43. Immunogenicity and transmission-blocking potential of quiescin sulfhydryl oxidase in Plasmodium vivax .

44. Plasmodium falciparum Mitochondrial Complex III, the Target of Atovaquone, Is Essential for Progression to the Transmissible Sexual Stages.

45. Single-cell transcriptomics reveal transcriptional programs underlying male and female cell fate during Plasmodium falciparum gametocytogenesis.

46. Compound K14 inhibits bacterial killing and protease activity in Dictyostelium discoideum phagosomes.

47. Comparative genome-wide identification and characterization of SET domain-containing and JmjC domain-containing proteins in piroplasms.

48. Hyper-diverse antigenic variation and resilience to transmission-reducing intervention in falciparum malaria.

49. A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites.

50. Characterization of Entamoeba fatty acid elongases; validation as targets and provision of promising leads for new drugs against amebiasis.

Catalog

Books, media, physical & digital resources